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Introduction
Levels of growth differentiation factor (GDF)-15, a stress-
responsive member of the transforming growth factor-b
cytokine superfamily, predict outcomes in cardiovascular
disease. However, the exact pathophysiological mecha-
nisms of GDF-15 in the cardiovascular system and in
acute ST-elevation myocardial infarction (STEMI) are not
well defined. Cardiovascular magnetic resonance (CMR)
imaging might be an imaging tool to further elucidate the
underlying mechanisms by reflecting myocardial necrosis
and microvascular obstruction (no reflow) with subse-
quent adverse infarct healing, adverse LV remodelling as
well as poor prognosis.
Purpose
To determine the relation between GDF-15 and infarct
size as well as microvascular obstruction assessed by CMR
imaging and to evaluate the prognostic value of GDF-15
in a high-risk STEMI population.
Methods
GDF-15 levels were determined by an enzyme-linked
immunoabsorbent assay in 238 consecutive patients
undergoing primary percutaneous coronary intervention
(PCI) in STEMI <12 hours after symptom onset. Patients
were categorized into 2 groups defined by the median
GDF-15 value on admission. All patients underwent CMR
for assessment of infarct size and microvascular obstruc-
tion. The primary clinical endpoint was mortality within
6 months after the index event.
Results
Reperfusion in STEMI using primary PCI resulted in a sig-
nificant GDF-15 level increase. Elevated GDF-15 levels on
admission were a strong predictor of mortality at six
months follow-up (19 versus 1 death, p < 0.001). GDF-15
levels on admission were not associated with other estab-
lished prognostic markers in STEMI patients including
infarct size, microvascular obstruction, pain-to-balloon
time, TIMI-flow before and after PCI as well as ST-resolu-
tion.
Conclusion
GDF-15 is a new, strong predictor of mortality in patients
with STEMI reperfused by primary PCI that provides prog-
nostic information beyond established CMR parameters
of clinical outcome. Thus, our study provides further
insights into the pathophysiological mechanisms of GDF-
15, supporting the hypothesis that GDF-15 integrates
information from different disease pathways in acute
STEMI and reflects unique additional prognostic informa-
tion.
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